Anne Steinø

533 total citations
30 papers, 201 citations indexed

About

Anne Steinø is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne Steinø has authored 30 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 15 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne Steinø's work include Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (8 papers) and DNA Repair Mechanisms (7 papers). Anne Steinø is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Brain Metastases and Treatment (8 papers) and DNA Repair Mechanisms (7 papers). Anne Steinø collaborates with scholars based in United States, Canada and Denmark. Anne Steinø's co-authors include Gunnar Houen, Charlotte Sværke Jørgensen, Nicole J. de Voogd, Raymond J. Andersen, A. Grant Mauk, Peter Højrup, Inga Laursen, Jesper S. Hansen, Niels H. H. Heegaard and David E. Williams and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Anne Steinø

27 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Steinø United States 8 77 58 41 40 34 30 201
Edward Cochran United States 6 102 1.3× 34 0.6× 15 0.4× 13 0.3× 20 0.6× 9 258
Osquel Barroso Spain 9 157 2.0× 124 2.1× 95 2.3× 9 0.2× 16 0.5× 13 374
Matthew J. Berberich United States 9 238 3.1× 56 1.0× 23 0.6× 12 0.3× 22 0.6× 15 344
Diego Garrido Ruiz United States 7 145 1.9× 15 0.3× 25 0.6× 17 0.4× 22 0.6× 9 232
Christopher M. Russo United States 12 139 1.8× 111 1.9× 8 0.2× 11 0.3× 10 0.3× 19 302
Xiaoke Chi Canada 9 385 5.0× 42 0.7× 34 0.8× 15 0.4× 14 0.4× 9 454
Tianlin Guo Canada 9 232 3.0× 66 1.1× 33 0.8× 31 0.8× 15 0.4× 13 326
Viacheslav V. Senichkin Sweden 8 241 3.1× 43 0.7× 21 0.5× 11 0.3× 24 0.7× 13 302
Jonathan Pratt Canada 7 144 1.9× 54 0.9× 27 0.7× 10 0.3× 3 0.1× 9 219

Countries citing papers authored by Anne Steinø

Since Specialization
Citations

This map shows the geographic impact of Anne Steinø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Steinø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Steinø more than expected).

Fields of papers citing papers by Anne Steinø

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Steinø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Steinø. The network helps show where Anne Steinø may publish in the future.

Co-authorship network of co-authors of Anne Steinø

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Steinø. A scholar is included among the top collaborators of Anne Steinø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Steinø. Anne Steinø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brien, Barbara, Marta Peñas-Prado, Carlos Kamiya-Matsuoka, et al.. (2021). CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. Neuro-Oncology. 23(Supplement_6). vi65–vi65. 1 indexed citations
2.
Zhai, Beibei, Yue Li, Sudha Sravanti Kotapalli, et al.. (2020). Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells. Cell Death and Disease. 11(7). 577–577. 4 indexed citations
3.
Al-Nakouzi, Nader, et al.. (2020). Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors. Cells. 9(4). 818–818. 8 indexed citations
4.
O’Brien, Barbara, John de Groot, Carlos Kamiya-Matsuoka, et al.. (2019). Abstract CT115: Phase II study of dianhydrogalactitol (VAL-083) in patients with MGMT-unmethylated, bevacizumab-naïve recurrent glioblastoma. Cancer Research. 79(13_Supplement). CT115–CT115. 1 indexed citations
5.
Golebiewska, Anna, et al.. (2019). Abstract 1051: Dianhydrogalactitol (VAL-083) reduces glioblastoma tumor growth upon bevacizumab-induced hypoxia, in vivo. Cancer Research. 79(13_Supplement). 1051–1051.
6.
Zhai, Beibei, et al.. (2018). Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination. Cell Death and Disease. 9(10). 1016–1016. 8 indexed citations
7.
Steinø, Anne, et al.. (2018). 48 Phase 2 studies of dianhydrogalactitol (VAL-083) in patients with glioblastoma, MGMT-unmethylated. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45(S3). S10–S10. 1 indexed citations
8.
O’Brien, Barbara, John de Groot, Carlos Kamiya-Matsuoka, et al.. (2018). ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA. Neuro-Oncology. 20(suppl_6). vi17–vi17. 3 indexed citations
9.
He, Guangan, et al.. (2018). Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors. Clinical Cancer Research. 24(15_Supplement). A01–A01. 1 indexed citations
10.
Zhai, Beibei, Guangan He, Anne Steinø, et al.. (2018). Abstract A109: DNA-damaging agent dianhydrogalactitol (VAL-083) targets HR repair pathway and suggests combination therapy with topoisomerase and PARP inhibitors. Molecular Cancer Therapeutics. 17(1_Supplement). A109–A109.
11.
Zhai, Beibei, et al.. (2016). Abstract 2985: Molecular mechanisms of dianhydrogalactitol (VAL-083) in cancer treatment. Cancer Research. 76(14_Supplement). 2985–2985.
12.
Shih, Kent C., Manish R. Patel, Nicholas Butowski, et al.. (2016). Phase I/II study of VAL-083 in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 34(15_suppl). 2063–2063. 2 indexed citations
13.
Fouse, Shaun D., Anne Steinø, Nicholas Butowski, et al.. (2015). Abstract 2562: Dianhydrogalactitol inhibits the growth of glioma stem and non-stem cultures, including temozolomide-resistant cell lines, in vitro and in vivo. Cancer Research. 75(15_Supplement). 2562–2562. 1 indexed citations
14.
Shih, Kent C., Manish R. Patel, Dennis Brown, et al.. (2014). Abstract CT404: Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme. Cancer Research. 74(19_Supplement). CT404–CT404. 1 indexed citations
15.
Steinø, Anne, Federico I. Rosell, Brian O. Patrick, et al.. (2014). Indoleamine 2,3-Dioxygenase Inhibitors Isolated from the Sponge Xestospongia vansoesti: Structure Elucidation, Analogue Synthesis, and Biological Activity. Organic Letters. 16(24). 6480–6483. 24 indexed citations
16.
Steinø, Anne, et al.. (2014). Abstract 824: In vivo efficacy of VAL-083 in the treatment of non-small cell lung cancer. Cancer Research. 74(19_Supplement). 824–824. 1 indexed citations
17.
Williams, David E., Anne Steinø, Nicole J. de Voogd, A. Grant Mauk, & Raymond J. Andersen. (2012). Halicloic Acids A and B Isolated from the Marine Sponge Haliclona sp. Collected in the Philippines Inhibit Indoleamine 2,3-Dioxygenase. Journal of Natural Products. 75(8). 1451–1458. 24 indexed citations
18.
Jørgensen, Christoffer Calov, Per Brinch Hansen, Anne Steinø, et al.. (2009). Interaction of the Chaperone Calreticulin with Proteins and Peptides of Different Structural Classes. Protein and Peptide Letters. 16(11). 1414–1423. 8 indexed citations
19.
Steinø, Anne, Charlotte Sværke Jørgensen, Inga Laursen, & Gunnar Houen. (2004). Interaction of C1q with the Receptor Calreticulin Requires a Conformational Change in C1q. Scandinavian Journal of Immunology. 59(5). 485–495. 27 indexed citations
20.
Jørgensen, Charlotte Sværke, Anne Steinø, Peter Højrup, et al.. (2003). Dimerization and oligomerization of the chaperone calreticulin. European Journal of Biochemistry. 270(20). 4140–4148. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Cochran Breakdown of academic impact, for papers by Osquel Barroso Breakdown of academic impact, for papers by Matthew J. Berberich Breakdown of academic impact, for papers by Diego Garrido Ruiz Breakdown of academic impact, for papers by Christopher M. Russo Breakdown of academic impact, for papers by Xiaoke Chi Breakdown of academic impact, for papers by Tianlin Guo Breakdown of academic impact, for papers by Viacheslav V. Senichkin Breakdown of academic impact, for papers by Jonathan Pratt
Rankless by CCL
2026